Enzymes substrate inhibition

The three reversible mechanisms for enzyme inhibition are distinguished by observing how changing the inhibitor s concentration affects the relationship between the rate of reaction and the concentration of substrate. As shown in figure 13.13, when kinetic data are displayed as a Lineweaver-Burk plot, it is possible to determine which mechanism is in effect. 

Chelation is a feature of much research on the development and mechanism of action of catalysts. For example, enzyme chemistry is aided by the study of reactions of simpler chelates that are models of enzyme reactions. Certain enzymes, coenzymes, and vitamins possess chelate stmctures that must be involved in the mechanism of their action. The activation of many enzymes by metal ions most likely involves chelation, probably bridging the enzyme and substrate through the metal atom. Enzyme inhibition may often result from the formation by the inhibitor of a chelate with a greater stabiUty constant than that of the substrate or the enzyme for a necessary metal ion. 

A PRACTICAL APPLICATION OF ENZYME INHIBITION BY A FALSE SUBSTRATE... 

In such inhibition, the inhibitor and die substrate can simultaneously bind to the enzyme. The nature of the enzyme-inhibitor-substrate binding has resulted in a ternary complex defined as EIS. The Ks and Kt are identical to the corresponding dissociation constants. It is also assumed that the EIS does not react further and is unable to deliver any product P. The rate equation for non-competitive inhibition, unvAX, is influenced ... 

Enzyme reaction kinetics were modelled on the basis of rapid equilibrium assumption. Rapid equilibrium condition (also known as quasi-equilibrium) assumes that only the early components of the reaction are at equilibrium.8-10 In rapid equilibrium conditions, the enzyme (E), substrate (S) and enzyme-substrate (ES), the central complex equilibrate rapidly compared with the dissociation rate of ES into E and product (P ). The combined inhibition effects by 2-ethoxyethanol as a non-competitive inhibitor and (S)-ibuprofen ester as an uncompetitive inhibition resulted in an overall mechanism, shown in Figure 5.20. 

For simple noncompetitive inhibition, E and EI possess identical affinity for substrate, and the EIS complex generates product at a negligible rate (Figure 8-10). More complex noncompetitive inhibition occurs when binding of the inhibitor does affect the apparent affinity of the enzyme for substrate, causing the tines to intercept in either the third or fourth quadrants of a double reciprocal plot (not shown). 

To refer to the kinetics of allosteric inhibition as competitive or noncompetitive with substrate carries misleading mechanistic implications. We refer instead to two classes of regulated enzymes K-series and V-se-ries enzymes. For K-series allosteric enzymes, the substrate saturation kinetics are competitive in the sense that is raised without an effect on V. For V-series allosteric enzymes, the allosteric inhibitor lowers... 

Group of enzyme Preferred substrate Inhibited by Representative enzymes... 

SCHEME 11.3 Postulated mechanisms for the inhibition of serine proteases by coumarin derivatives. NuH nucleophile. Pathway a suicide-type inactivation (suicide substrate). Pathway b transient inactivation by formation of a stable acyl-enzyme (alternate substrate-inhibitor). 

If administration of a compound to cells results in inhibition of the target enzyme within the cell, one should expect the intracellular levels of the substrate for the target enzyme to increase because of inhibition. Likewise inhibition of the target enzyme abrogates product formation hence one should observe a diminution of product as a result of enzyme inhibition within the cell. The compound concentration dependence of substrate buildup and/or product diminution (i.e., the EC50 for... 

D. H. Rich, M. S. Bematowicz, N. S. Agarwal, M. Kawai, F. G. Salituro, and P. G. Schmidt, Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition, Biochemistry 24 3165... 

Substrates may affect enzyme kinetics either by activation or by inhibition. Substrate activation may be observed if the enzyme has two (or more) binding sites, and substrate binding at one site enhances the alfinity of the substrate for the other site(s). The result is a highly active ternary complex, consisting of the enzyme and two substrate molecules, which subsequently dissociates to generate the product. Substrate inhibition may occur in a similar way, except that the ternary complex is nonreactive. We consider first, by means of an example, inhibition by a single substrate, and second, inhibition by multiple substrates. 

The inhibition process in general may be represented by the following six-step scheme (a similar scheme may be used for activation-see problem 10-12), in which I is the inhibitor, El is a binary enzyme-inhibitor complex, and EIS is a ternary enzyme-inhibitor-substrate complex. 

If a drug is a substrate of an enzyme, it will also be a competitive inhibitor of that enzyme, but it may be a competitive inhibitor without being a substrate. This is because the rate of product formation is determined by k3 of the Michaelis-Menten equation while the rate of ES substrate dissociation and degree of enzyme inhibition is determined by the ratio of A/a i as discussed above. If A 3 is very small it will not be experimentally measurable however, the enzyme will still be bound and occupied as determined by ki/k. ... 

A reciprocal plot of the effect of varying concentrations of a noncompetitive inhibitor on enzyme-catalyzed substrate turnover readily reveals the nature and characteristics of this type of inhibition (Fig. 3.6). Notice that in this case, the properties that characterize noncompetitive inhibition are virtually opposite of those that characterize competitive inhibition. With a noncompetitive inhibitor Emax does change but KM is constant. 

Allenic amino acids belong to the classical suicide substrates for the irreversible mechanism-based inhibition of enzymes [5], Among the different types of allenic substrates used for enzyme inhibition [128, 129], the deactivation of vitamin B6 (pyr-idoxal phosphate)-dependent decarboxylases by a-allenic a-amino acids plays an important role (Scheme 18.45). In analogy with the corresponding activity of other /3,y-unsaturated amino acids [102,130], it is assumed that the allenic amino acid 139 reacts with the decarboxylase 138 to furnish the imine 140, which is transformed into a Michael acceptor of type 141 by decarboxylation or deprotonation. Subsequent attack of a suitable nucleophilic group of the active site then leads to inhibition of the decarboxylase by irreversible formation of the adduct 142 [131,132]. 

Nau WM, Ghale G, Hennig A et al (2009) Substrate-selective supramolecular tandem assays monitoring enzyme inhibition of arginase and diamine oxidase by fluorescent dye displacement from calixarene and cucurbituril macrocycles. J Am Chem Soc 131 11558-11570... 

---